VitalAire inaugurates the first consultation healthcare for patients with Valencia respiratory ailments
consultation serves to patients with diseases such as apnea sleep, COPD or cystic fibrosis, affecting more than 5% of the population of Valencia.
Valencia, April 2012.- on 27 March took place the inauguration of the first consultation for patients with respiratory ailments called Valencia orange point consultation: point is a meeting place for patients and prescribers and orange as the symbol and the identifying color of the Valencian Community, as well as one of the colors of the logo of VitalAire.
The opening they have attended, among other personalities, Counsellor Mr. D. Luis Eduardo Rosado Breton, the Councillor of health of the city of Valencia, Doña Lourdes Bernal, and D. Philippe Lecerf, Director General of VitalAire in the Iberian Peninsula.
The consultation point orange is strategically located between the Valencian capital referral hospitals to facilitate access to patients.
This Centre and under the indication of the medical prescribing may call people with respiratory diseases such as COPD (pulmonary obstructive chronic disease), Apnea sleep (SHAHS), cystic fibrosis or restrictive pathologies, among others, which will be attended by nurses and physical therapists available in the consultation. His work consists of informing them, resolve technical questions relating to the equipment installed in his home and train them or reinforce the acquired knowledge about their disease, according to the clinical protocols – care established by your doctor prescriber.
Awareness of the person with respiratory pathology and the key role that has its caretaker is of great importance for VitalAire, to improve the quality of life of patients. Protect the patient, help prevent possible acute episodes or potential income, means managing form effective and allow the health system to be more sustainable, thanks to reductions in hospitalizations. These diseases affect approximately 35,000 people in Valencia.
According to the pathology of the treatment, each patient will receive in different specific areas has the query. These are treatment of sleep, adaptation to oxygen therapy of walking or training in respiratory therapies paciente-tutor ”, which will make it possible to offer a more personalized service to each patient.
In the words of Philippe Lecerf, CEO of VitalAire in the Iberian Peninsula: thanks to the opening of this new consultation only in Valencia, VitalAire can offer not only the equipment needed for the treatments, but motivational and educational media to achieve our goal: improve the quality of life of our patients ”.
Air Liquide
Air Liquide is the world leader in gases for industry, health and the environment and is present in 80 countries with 46.200 collaborators. Oxygen, nitrogen, hydrogen and the noble gases are at the heart of the activity of Air Liquide since its creation in 1902. From these molecules Air Liquide continuously reinvents its business to anticipate the challenges of their present and future markets. The Group innovates to enable progress, at the time that excels in getting together a dynamic growth and regularity in their results.
Innovative technologies to limit emissions, reduce energy consumption of industry, put in value natural resources or develop the energies of tomorrow, such as hydrogen, biofuels or photovoltaic energy … oxygen for hospitals, home care, contribute to the fight against nosocomial diseases … Air Liquide combines many products with various technologies to develop applications and services with strong added value for its customers and society.
A partner for the long term. The Group relies on the commitment of its employees, the confidence of its customers and the support of its shareholders to develop a long-term focus on competitive growth vision. The diversity of its teams, activities, markets and geographical presence ensures the soundness and sustainability of their development, and strengthens its ability to continuously conquer new territories to overcome its own limits, and build their future.
Air Liquide explores the best that air can offer to preserve life, maintain a dynamic of responsibility and of sustainable development. In 2011, its turnover reached 14,500 million EUR of which more than 80% out of France. Air Liquide is listed on the stock exchange of Euronext Paris (compartment A) and is part of the CAC index 40 et Dow Jones Euro Stoxx 50.